Quoin Pharmaceuticals, Ltd.
QNRX
$19.00
-$0.17-0.89%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.22% | 10.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.98% | -4.14% | |||
| Operating Income | -5.98% | 4.14% | |||
| Income Before Tax | -6.83% | 3.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.83% | 3.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.83% | 3.05% | |||
| EBIT | -5.98% | 4.14% | |||
| EBITDA | -6.02% | 4.17% | |||
| EPS Basic | -6.83% | 3.35% | |||
| Normalized Basic EPS | -6.82% | 3.35% | |||
| EPS Diluted | -6.67% | 3.10% | |||
| Normalized Diluted EPS | -6.82% | 3.35% | |||
| Average Basic Shares Outstanding | 0.00% | 0.32% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||